Takafumi Matsumoto

发表

Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats

Y. Nakayama, Katsushi Yamada, A. Saigo, 1993, Neuroscience Letters.

Discovery of furan-2-carbohydrazides as orally active glucagon receptor antagonists.

M. Murata, Futoshi Hasegawa, A. Fujii, 2014, Bioorganic & medicinal chemistry letters.

A spontaneously immortalized Schwann cell line from aldose reductase‐deficient mice as a useful tool for studying polyol pathway and aldehyde metabolism

K. Sango, Y. Nishito, S. Yagihashi, 2018, Journal of neurochemistry.

Improvement of motor nerve conduction velocity in diabetic rats requires normalization of the polyol pathway metabolites flux.

V. Bril, Y. Ono, K. Nakamura, 2009, Journal of pharmacological sciences.

Ranirestat (AS-3201), a potent aldose reductase inhibitor, reduces sorbitol levels and improves motor nerve conduction velocity in streptozotocin-diabetic rats.

V. Bril, Y. Ono, K. Nakamura, 2008, Journal of pharmacological sciences.

Long-term treatment with ranirestat (AS-3201), a potent aldose reductase inhibitor, suppresses diabetic neuropathy and cataract formation in rats.

V. Bril, Y. Ono, K. Toyosawa, 2008, Journal of pharmacological sciences.

Prophylactic Medical Treatment of Diabetic Retinopathy

W. Fujimoto, Y. Dobashi, M. Kawakami, 2012 .

Ranirestat has a stronger inhibitory activity on aldose reductase and suppresses inflammatory reactions in high glucose–exposed endothelial cells

S. Yamagishi, T. Matsui, Y. Ishibashi, 2016, Diabetes & vascular disease research.

The mechanism of central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the hypothalamus in rats

Y. Nakayama, H. Kamiya, Y. Takano, 1993, Regulatory Peptides.

Effect of Ranirestat, a New Aldose Reductase Inhibitor, on Diabetic Retinopathy in SDT Rats

A. Kakehashi, H. Takano, N. Kinoshita, 2014, Journal of diabetes research.

Effects of Long-Term Treatment with Ranirestat, a Potent Aldose Reductase Inhibitor, on Diabetic Cataract and Neuropathy in Spontaneously Diabetic Torii Rats

W. Fujimoto, Y. Dobashi, M. Kawakami, 2013, Journal of diabetes research.

Aldose reductase inhibitor counteracts the enhanced expression of matrix metalloproteinase-10 and improves corneal wound healing in galactose-fed rats

Y. Takamura, M. Inatani, Yuji Takihara, 2013, Molecular vision.